Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Oleanolic acid improved hair growth in mice by affecting hair growth pathways and reducing inflammation.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Biofield Energy Healing may increase hair growth by enhancing cell proliferation.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

HuR is essential for Treg function and preventing autoimmunity.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

North American ginseng extract helped regrow hair in balding mice.

Metabolic signals and cell shape influence how cells develop and change.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

15-lipoxygenase helps keep skin healthy by reducing inflammation.

Hair follicle size is mainly influenced by the number of cells and extracellular matrix volume, with cell number having a larger impact.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.